BERLIN-FARMA, ZAO, Moscow

Accounting reports

Previously








Share:
Name
BERLIN-FARMA, ZAO
INN
7714033558
KPP
402901001
OGRN
1027739581968
OKPO
40305100
Address
248926, Kaluzhskaya Oblast', g Kaluga, pr-d 2-y Avtomobil'nyy, d. D. 5
Phone
+7 (484) 290-95-00
Fax
90-95-01

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
BERLIN-FARMA, ZAO according to EGRUL

OKVED codeTypeName of activity type
21.20.1Core activity Production of drugs
Registration date
20.11.2002
Registering department
Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata

BERLIN-FARMA, ZAO (Moscow; INN 7714033558) was registered on 20 Nov 2002. The company's authorized capital as of July 1, 2012 was 900100000 rub.

Type of ownership of BERLIN-FARMA, ZAO - Closed joint-stock companies.

Form of ownership of BERLIN-FARMA, ZAO - Property of foreign legal entities.

Principal activities of BERLIN-FARMA, ZAO: production of drugs (21.20.1).

Economic indicators

2022

Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2022 by 11.73% to 275.05 million RUB from 311.60 million RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period by 27.34% to 4.15 billion RUB from 5.71 billion RUB in 2021; cost of goods sold decreased by 30.32% to 3.63 billion RUB from 5.20 billion RUB; sales profit went up by 5.44% to 419.89 million RUB from 398.24 million RUB.

2021

Net profit (RAS) of BERLIN-FARMA, ZAO grew over 2021 by 4.64% to 311.60 million RUB from 297.79 million RUB over 2020, the company informed.

Revenue increased in the accounting period by 15.16% to 5.71 billion RUB from 4.95 billion RUB over 2020; cost of goods sold grew by 17.01% to 5.20 billion RUB from 4.45 billion RUB; sales profit fell by 1.25% to 398.24 million RUB from 403.28 million RUB.

2020

Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2020 by 34.69% to 297.79 million RUB from 455.95 million RUB over the same period in 2019, the company informed.

Revenue decreased in the accounting period by 15.40% to 4.95 billion RUB from 5.86 billion RUB in 2019; cost of goods sold decreased by 14.16% to 4.54 billion RUB from 5.29 billion RUB; sales profit fell by 27.90% to 403.28 million RUB from 559.31 million RUB.

2018

Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2018 2.47 times to 236.95 million RUB from 586.05 million RUB over the same period in 2017, the company informed.

Revenue increased in the accounting period by 19.28% to 4.34 billion RUB from 3.64 billion RUB over 2017; cost of goods sold grew by 43.19% to 4.17 billion RUB from 2.91 billion RUB; sales profit fell 4.29 times to 168.90 million RUB from 725.06 million RUB.

2017

Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2017 by 38.79% to 586.05 million RUB from 957.37 million RUB over the same period in 2016, the company informed.

Revenue increased in the accounting period by 5.81% to 3.64 billion RUB from 3.44 billion RUB over 2016; cost of goods sold grew by 20.14% to 2.91 billion RUB from 2.42 billion RUB; sales profit fell by 28.47% to 725.06 million RUB from 1.01 billion RUB.

2016

Net profit (RAS) of BERLIN-FARMA, ZAO grew over 2016 4.89 times to 956.56 million RUB from 195.64 million RUB over 2015, the company informed.

Revenue increased in the accounting period by 46.72% to 3.44 billion RUB from 2.35 billion RUB over 2015; cost of goods sold grew by 37.08% to 2.42 billion RUB from 1.77 billion RUB; sales profit went up 1.76 times to 1.01 billion RUB from 574.46 million RUB.

2014

Net loss (RAS) of BERLIN-FARMA, ZAO increased 2.35 times to 444.89 million RUB from 189.08 million RUB over 2013, the company informed.

Sales profit made up 162.48 million RUB compared to sales loss of 239.67 million RUB.

2013

Net loss (RA) of BERLIN-FARMA, ZAO made up 199.54 million RUB over 2013 compared to net profit of 258.62 million RUB over 2012, the company informed.

Revenue decreased in the accounting period 442.28 times to 24.31 million RUB from 10.75 billion RUB in 2012; cost of goods sold decreased 1,920.67 times to 5.53 million RUB from 10.62 billion RUB; sales profit made up 18.78 million RUB compared to sales loss of 164.67 million RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 196 448
Reports
17 430 848
Rrocessed requests
Extract from EGRUL:
Today, 10:30 AM
Accounting reports:
Today, 10:31 AM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2024
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru